Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week launched Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE).
Read More
HARRISBURG, PA — Attorney General Josh Shapiro announced the third lawsuit from the ongoing antitrust investigation into generic drug manufacturers who are artificially inflating and manipulating prices, costing consumers millions in …
Read More
MALVERN, PA — Phlexglobal, a leading innovative technology and services provider for the life sciences industry, recently announced its substantial contribution to COVID-19 clinical trial activities. Since the outbreak of …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, recently reported financial results from the …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, reported financial results for the first quarter ended …
Read More
SILVER SPRING, MD — The U.S. Food and Drug Administration is taking important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance …
Read More
DEVON, PA — Coeus Consulting Group, a leading boutique life science consulting firm, announced it has hired two executives to help grow and manage the company’s enhanced market access offerings. …
Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved ophthalmic diseases, recently reported full year 2019 …
Read More
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) a leading contract development and manufacturing organization (CDMO) with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug …
Read More